False-Positive Human Immunodeficiency Virus Enzyme Immunoassay Results in Pregnant Women
Open Access
- 27 January 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (1) , e16538
Abstract
Examine whether false-positive HIV enzyme immunoassay (EIA) test results occur more frequently among pregnant women than among women who are not pregnant and men (others). To obtain a large number of pregnant women and others tested for HIV, we identified specimens tested at a national laboratory using Genetic Systems HIV-1/HIV-2 Plus O EIA from July 2007 to June 2008. Specimens with EIA repeatedly reactive and Western blot-negative or indeterminate results were considered EIA false-positive. We compared the false-positive rate among uninfected pregnant women and others, adjusting for HIV prevalence. Among all reactive EIAs, we evaluated the proportion of false-positives, positive predictive value (PPV), and Western blot bands among indeterminates, by pregnancy status. HIV prevalence was 0.06% among 921,438 pregnant women and 1.34% among 1,103,961 others. The false-positive rate was lower for pregnant women than others (0.14% vs. 0.21%, odds ratio 0.65 [95% confidence interval 0.61, 0.70]). Pregnant women with reactive EIAs were more likely than others (p<0.01) to have Western blot-negative (52.9% vs. 9.8%) and indeterminate results (17.0% vs. 3.7%) and lower PPV (30% vs. 87%). The p24 band was detected more often among pregnant women (p<0.01). False-positive HIV EIA results were rare and occurred less frequently among pregnant women than others. Pregnant women with reactive EIAs were more likely to have negative and indeterminate Western blot results due to lower HIV prevalence and higher p24 reactivity, respectively. Indeterminate results may complicate clinical management during pregnancy. Alternative methods are needed to rule out infection in persons with reactive EIAs from low prevalence populations.Keywords
This publication has 22 references indexed in Scilit:
- Performance of an automated human immunodeficiency virus (HIV) antigen/antibody combined assay for prenatal screening for HIV infection in pregnant womenJournal of Medical Microbiology, 2009
- HIV Testing and Prophylaxis to Prevent Mother-to-Child Transmission in the United StatesPediatrics, 2008
- ACOG Committee Opinion No. 418: Prenatal and Perinatal Human Immunodeficiency Virus Testing: Expanded RecommendationsObstetrics & Gynecology, 2008
- Estimation of HIV Incidence in the United StatesJAMA, 2008
- Alternative Algorithms for Human Immunodeficiency Virus Infection Diagnosis Using Tests That Are Licensed in the United StatesJournal of Clinical Microbiology, 2008
- Repeat Confirmatory Testing for Persons with Discordant Whole Blood and Oral Fluid Rapid HIV Test Results: Findings from Post Marketing SurveillancePLOS ONE, 2008
- HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementationTransfusion, 2003
- Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United StatesRevised November 3, 2000HIV Research & Clinical Practice, 2001
- Human Immunodeficiency Virus ScreeningPediatrics, 1999
- Long‐term follow‐up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blotTransfusion, 1995